Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 24 of 324 entries
Sorted by: Best Match Show Resources per page
Exploring genetic susceptibility to cancer in diverse populations.

Current opinion in genetics & development

Haiman CA, Stram DO.
PMID: 20359883
Curr Opin Genet Dev. 2010 Jun;20(3):330-5. doi: 10.1016/j.gde.2010.02.007. Epub 2010 Mar 30.

Incidence rates for many cancers differ markedly by race/ethnicity and furthering our understanding of the genetic and environmental causes of such disparities is a scientific and public health need. Genome-wide association studies (GWAS) are widely acknowledged to provide important...

Charged to Medicare: how much is too much?.

Proceedings (Baylor University. Medical Center)

Haiman RG.
PMID: 16252036
Proc (Bayl Univ Med Cent). 2005 Oct;18(4):410-1. doi: 10.1080/08998280.2005.11928105.

No abstract available.

Progressive resistance training program for improving manual materials handling performance.

Work (Reading, Mass.)

Sharp MA, Harman EA, Boutilier BE, Bovee MW, Kraemer WJ.
PMID: 24442116
Work. 1993;3(3):62-8. doi: 10.3233/WOR-1993-3308.

No abstract available.

Patient feedback via a national registry could improve physicians' CME.

Academic medicine : journal of the Association of American Medical Colleges

Hariman CH, Bateman J, Bond J.
PMID: 22531579
Acad Med. 2012 May;87(5):549; author reply 549. doi: 10.1097/ACM.0b013e31824d5432.

No abstract available.

Global patterns of prostate cancer incidence, aggressiveness, and mortality in men of african descent.

Prostate cancer

Rebbeck TR, Devesa SS, Chang BL, Bunker CH, Cheng I, Cooney K, Eeles R, Fernandez P, Giri VN, Gueye SM, Haiman CA, Henderson BE, Heyns CF, Hu JJ, Ingles SA, Isaacs W, Jalloh M, John EM, Kibel AS, Kidd LR, Layne P, Leach RJ, Neslund-Dudas C, Okobia MN, Ostrander EA, Park JY, Patrick AL, Phelan CM, Ragin C, Roberts RA, Rybicki BA, Stanford JL, Strom S, Thompson IM, Witte J, Xu J, Yeboah E, Hsing AW, Zeigler-Johnson CM.
PMID: 23476788
Prostate Cancer. 2013;2013:560857. doi: 10.1155/2013/560857. Epub 2013 Feb 13.

Prostate cancer (CaP) is the leading cancer among men of African descent in the USA, Caribbean, and Sub-Saharan Africa (SSA). The estimated number of CaP deaths in SSA during 2008 was more than five times that among African Americans...

Unconventional application of gold nanoclusters/Zn-MOF composite for fluorescence turn-on sensitive detection of zinc ion.

Analytica chimica acta

Li Y, Hu X, Zhang X, Cao H, Huang Y.
PMID: 29776540
Anal Chim Acta. 2018 Sep 18;1024:145-152. doi: 10.1016/j.aca.2018.04.016. Epub 2018 Apr 18.

Contrary to organic solvent-induced aggregation of Au nanoclusters (AuNCs), herein, we reported aggregation induced emission enhancement (AIEE) of AuNCs in an aqueous media through confinement of AuNCs by in situ formed Zn-MOF for detecting Zn

Melanoma in situ: a case report from the patient's perspective.

The Journal of the Canadian Chiropractic Association

Bauman CA, Emary P, Damen T, Dixon H.
PMID: 30270928
J Can Chiropr Assoc. 2018 Apr;62(1):56-61.

INTRODUCTION: Melanoma can be a fatal form of skin cancer. The prognosis rapidly deteriorates from the in situ stage (stage 0) to stage 4. As such, early detection and treatment are key.CASE PRESENTATION: A middle-aged patient, who was also...

Sinomenine derivative YL064: a novel STAT3 inhibitor with promising anti-myeloma activity.

Cell death & disease

Wang Y, Wu L, Cai H, Lei H, Ma CM, Yang L, Xu H, Zhu Q, Yao Z, Wu Y.
PMID: 30361529
Cell Death Dis. 2018 Oct 25;9(11):1093. doi: 10.1038/s41419-018-1147-z.

No abstract available.

Structural basis of a novel PD-L1 nanobody for immune checkpoint blockade.

Cell discovery

Zhang F, Wei H, Wang X, Bai Y, Wang P, Wu J, Jiang X, Wang Y, Cai H, Xu T, Zhou A.
PMID: 28280600
Cell Discov. 2017 Mar 07;3:17004. doi: 10.1038/celldisc.2017.4. eCollection 2017.

The use of antibodies to target immune checkpoints, particularly PD-1/PD-L1, has made a profound impact in the field of cancer immunotherapy. Here, we identified KN035, an anti-PD-L1 nanobody that can strongly induce T-cell responses and inhibit tumor growth. The...

Publisher Correction: Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation.

Nature communications

Ghoussaini M, Edwards SL, Michailidou K, Nord S, Cowper-Sal Lari R, Desai K, Kar S, Hillman KM, Kaufmann S, Glubb DM, Beesley J, Dennis J, Bolla MK, Wang Q, Dicks E, Guo Q, Schmidt MK, Shah M, Luben R, Brown J, Czene K, Darabi H, Eriksson M, Klevebring D, Bojesen SE, Nordestgaard BG, Nielsen SF, Flyger H, Lambrechts D, Thienpont B, Neven P, Wildiers H, Broeks A, Van't Veer LJ, Rutgers EJT, Couch FJ, Olson JE, Hallberg E, Vachon C, Chang-Claude J, Rudolph A, Seibold P, Flesch-Janys D, Peto J, Dos-Santos-Silva I, Gibson L, Nevanlinna H, Muranen TA, Aittomäki K, Blomqvist C, Hall P, Li J, Liu J, Humphreys K, Kang D, Choi JY, Park SK, Noh DY, Matsuo K, Ito H, Iwata H, Yatabe Y, Guénel P, Truong T, Menegaux F, Sanchez M, Burwinkel B, Marme F, Schneeweiss A, Sohn C, Wu AH, Tseng CC, Van Den Berg D, Stram DO, Benitez J, Pilar Zamora M, Perez JIA, Menéndez P, Shu XO, Lu W, Gao YT, Cai Q, Cox A, Cross SS, Reed MWR, Andrulis IL, Knight JA, Glendon G, Tchatchou S, Sawyer EJ, Tomlinson I, Kerin MJ, Miller N, Haiman CA, Henderson BE, Schumacher F, Le Marchand L, Lindblom A, Margolin S, Teo SH, Yip CH, Lee DSC, Wong TY, Hooning MJ, Martens JWM, Collée JM, van Deurzen CHM, Hopper JL, Southey MC, Tsimiklis H, Kapuscinski MK, Shen CY, Wu PE, Yu JC, Chen ST, Alnæs GG, Borresen-Dale AL, Giles GG, Milne RL, McLean C, Muir K, Lophatananon A, Stewart-Brown S, Siriwanarangsan P, Hartman M, Miao H, Buhari SABS, Teo YY, Fasching PA, Haeberle L, Ekici AB, Beckmann MW, Brenner H, Dieffenbach AK, Arndt V, Stegmaier C, Swerdlow A, Ashworth A, Orr N, Schoemaker MJ, García-Closas M, Figueroa J, Chanock SJ, Lissowska J, Simard J, Goldberg MS, Labrèche F, Dumont M, Winqvist R, Pylkäs K, Jukkola-Vuorinen A, Brauch H, Brüning T, Koto YD, Radice P, Peterlongo P, Bonanni B, Volorio S, Dörk T, Bogdanova NV, Helbig S, Mannermaa A, Kataja V, Kosma VM, Hartikainen JM, Devilee P, Tollenaar RAEM, Seynaeve C, Van Asperen CJ, Jakubowska A, Lubinski J, Jaworska-Bieniek K, Durda K, Slager S, Toland AE, Ambrosone CB, Yannoukakos D, Sangrajrang S, Gaborieau V, Brennan P, McKay J, Hamann U, Torres D, Zheng W, Long J, Anton-Culver H, Neuhausen SL, Luccarini C, Baynes C, Ahmed S, Maranian M, Healey CS, González-Neira A, Pita G, Rosario Alonso M, Álvarez N, Herrero D, Tessier DC, Vincent D, Bacot F, de Santiago I, Carroll J, Caldas C, Brown MA, Lupien M, Kristensen VN, Pharoah PDP, Chenevix-Trench G, French JD, Easton DF, Dunning AM.
PMID: 29633761
Nat Commun. 2018 Apr 10;9:16193. doi: 10.1038/ncomms16193.

This corrects the article DOI: 10.1038/ncomms5999.

No Association between Cortical Gyrification or Intrinsic Curvature and Attention-deficit/Hyperactivity Disorder in Adolescents and Young Adults.

Frontiers in neuroscience

Forde NJ, Ronan L, Zwiers MP, Alexander-Bloch AF, Faraone SV, Oosterlaan J, Heslenfeld DJ, Hartman CA, Buitelaar JK, Hoekstra PJ.
PMID: 28473750
Front Neurosci. 2017 Apr 20;11:218. doi: 10.3389/fnins.2017.00218. eCollection 2017.

Magnetic resonance imaging (MRI) studies have highlighted subcortical, cortical, and structural connectivity abnormalities associated with attention-deficit/hyperactivity disorder (ADHD). Gyrification investigations of the cortex have been inconsistent and largely negative, potentially due to a lack of sensitivity of the previously...

WP1130 reveals USP24 as a novel target in T-cell acute lymphoblastic leukemia.

Cancer cell international

Luo H, Jing B, Xia Y, Zhang Y, Hu M, Cai H, Tong Y, Zhou L, Yang L, Yang J, Lei H, Xu H, Liu C, Wu Y.
PMID: 30911287
Cancer Cell Int. 2019 Mar 13;19:56. doi: 10.1186/s12935-019-0773-6. eCollection 2019.

BACKGROUND: T-cell acute lymphoblastic leukemia (T-ALL) is a lymphoid malignancy caused by the oncogenic transformation of immature T-cell progenitors with poor outcomes. WP1130 has shown potent activity against a variety of cancer but whether WP1130 has anti-T-ALL activity is...

Showing 13 to 24 of 324 entries